Samsara Bio Capital, LLC has filed its 13F form on November 14, 2025 for Q3 2025 where it was disclosed a total value porftolio of $264 Million distributed in 27 stocks.
Among their holdings, we can observe that their the top five positions include companies like: Scholar Rock Holding Corp with a value of $210M, Gossamer Bio, Inc. with a value of $16.1M, Aquestive Therapeutics, Inc. with a value of $14M, Nkarta, Inc. with a value of $7.8M, and Arcellx, Inc. with a value of $6.66M.
Examining the 13F form we can see an increase of $31M in the current position value, from $233M to 264M.
Samsara Bio Capital, LLC is based out at Palo Alto, CA
Below you can find more details about Samsara Bio Capital, LLC portfolio as well as his latest detailed transactions.
